Navigation Links
Study finds heart failure is rare among leukemia patients on imatinib
Date:9/6/2007

HOUSTON - Congestive heart failure rarely occurs among leukemia patients who take imatinib, researchers at The University of Texas M. D. Anderson Cancer Center found after an exhaustive review of the detailed medical histories of 1,276 patients who enrolled in clinical trials for the drug.

Researchers found 22 patients, or 1.7 percent, had symptoms that could have been caused by heart failure. Of those, 18 had previous medical conditions that could also cause heart failure, such as type II diabetes, hypertension, irregular heartbeat or coronary artery disease. Six had congestive heart failure before entering treatment. The results were reported in the Aug. 15 edition of the journal Blood.

"Imatinib remains a safe drug, but monitoring patients and knowing their medical histories are always important," says Jorge Cortes, M.D., senior author of the report and professor in M. D. Anderson's Department of Leukemia. "There is no current need for routine cardiac-specific monitoring of all patients taking imatinib. However, those with significant cardiac history need to be closely monitored. Patients who develop symptoms of heart failure should be evaluated carefully and treated with standard therapy."

Of the 22 patients found to have cardiovascular conditions, 11 were able to continue on imatinib for their leukemia after dose adjustments and management of the heart failure symptoms. The standard of care for treatment includes the use of beta blockers and angiotensin converting enzyme inhibitors or angiotensin receptor blockers, notes study co-author Jean-Bernard Durand, M.D., an assistant professor in M. D. Anderson's Department of Cardiology. Both classes of drugs are approved by the FDA for treatment of heart failure and recommended by the Heart Failure Society of America.

The team also found the incidence of congestive heart failure among patients receiving imatinib to be comparable to the expected incidence in the general pop
'/>"/>

Contact: Scott Merville
sdmervil@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Gene study links endometriosis, infertility
2. Study reveals how stress can make you sick
3. Study points out that HIV vaccine may not be accepted easily
4. A new study surpasses Gene Therapy Hurdle
5. Tomato Sauce reduces Cancer Risk- Study
6. A question on study of Adult Stem Cell
7. Study on obesity and heart failure
8. National Lung Study in the process
9. Marijuana gateway theory strengthened by study of twins
10. Old theory of adaptation confirmed by new study
11. Study casts doubt on keyboard ills
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2015)... ... August 30, 2015 , ... Nutritional Products ... lead the expansion of global cosmeceutical and skin care brands. Mr. Fernandez ... the last 25 years working in operations, purchasing and management for some of ...
(Date:8/29/2015)... (PRWEB) , ... August 30, 2015 , ... ... Sept. 15, 2015 — 1:30 p.m. – 3:00 p.m. EDT, http://www.fdanews.com/electronicinformedconsent ... than a simple digital handwritten signature. , Clinical trial sites can ...
(Date:8/29/2015)... ... August 29, 2015 , ... Dr. Tim Novelli, DC., Founder ... mission is to increase acceptance of the chiropractic field in the military. All too ... them. Although Chiropractic was made available to the VA program over a decade ...
(Date:8/29/2015)... ... August 29, 2015 , ... ... the localized area with stretching, soft tissue manipulation. Platelet rich plasma injections also ... shown through research to improve treatment outcomes. This localized treatment seems to ...
(Date:8/28/2015)... Nevada (PRWEB) , ... August 28, 2015 , ... An ... its decision to make the purchase of CPAP equipment more affordable by offering shipping ... includes all types of CPAP products and orders of any size. My Cpap Store ...
Breaking Medicine News(10 mins):Health News:NPI Executive Vice President Leads Cosmeceutical Expansion 2Health News:FDAnews Announces — Electronic Informed Consent for Clinical Trials: Best Practices Webinar, Sept. 15, 2015 2Health News:FDAnews Announces — Electronic Informed Consent for Clinical Trials: Best Practices Webinar, Sept. 15, 2015 3Health News:FDAnews Announces — Electronic Informed Consent for Clinical Trials: Best Practices Webinar, Sept. 15, 2015 4Health News:The Patriot Project brings Chiropractic Care to the Armed Forces and their Families - Rapid Release Technology Joins the Effort to Recruit more Doctors to Pledge 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 3Health News:My Cpap Store Now Offering Delivery Special 0 Cost to You 2
... to smoke or consume high doses of caffeine ... the disease//, according to a report. ... (NSAID) medications (such as aspirin, ibuprofen and naproxen) ... Parkinson's disease, according to background information in the ...
... published in the April 10, 2007, issue of Neurology, ... patients// suffering ‘Restless Legs Syndrome (RLS). The risk increases ... conducted at the University of Montreal’s Sacré-Coeur Hospital, ten ... sleep laboratory, where researchers monitored periodic leg movements and ...
... Canadian report has come out with news that would gladden ... as strike fear// in the minds of their western ... of the McLaughlin-Rotman Center for Global Health in Toronto, Canada, ... and ill health". The report published in ...
... by Banfield, The Pet Hospital, one of the largest chains ... dogs// were sickened or killed nationwide consequent on pet food-contamination ... reportedly compiled from records collected from more than 615 veterinary ... contaminated pet food. Described as one of the largest in ...
... from one moment to the next, and experts say the ... psychological after-effects. ,"Every person reacts differently to shock," ... services in the northern German port city of Hamburg. ... screaming is seldom the case, she says. "Some people are ...
... to the U.S. Department of Energy's Brookhaven National Laboratory ... the U.S. Patent Number 7,179,448 which will allow them ... the development of vaccines and diagnostic tests for Lyme ... of two proteins that are normally present on the ...
Cached Medicine News:Health News:Smoking and Caffeine Inversely Associated With Parkinson's Disease 2Health News:Restless Legs Syndrome Poses Risk of Cardiovascular Disease 2Health News:India’s Biotech Companies- Jumbos Waiting to Gro 2Health News:Melamine Contamination Killed Thousands of Pets, Says a New Report 2Health News:Accident Victims Often Need Psychological Help 2Health News:Scientists Receive Patent for Development of "combination" Proteins to Produce Vaccines for Lyme Disease 2Health News:Scientists Receive Patent for Development of "combination" Proteins to Produce Vaccines for Lyme Disease 3
(Date:8/28/2015)...  Today, in final recognition of the Centers for ... 1-800 Contacts is sharing how to keep lens cases ... who do not properly care for their lens cases ... Most contact lens wearers understand the importance ... case is sometimes overlooked.  When proper steps to clean ...
(Date:8/28/2015)... DUBLIN , Aug. 28, 2015 ... ) has announced the addition of the ... report to their offering. Developed by ... selective prostaglandin receptor agonist which effectively reduces intraocular ... by FDA, latanoprost (under the trade name of ...
(Date:8/28/2015)... 28, 2015 Perrigo Company plc ("Perrigo") (NYSE: ... N.V. ("Mylan") (NASDAQ: MYL ) shareholder vote regarding ... "Our views of Mylan,s offer to Perrigo shareholders have ... our Board,s careful reflection of the value available to ... choices that Mylan has allowed its shareholders to consider," ...
Breaking Medicine Technology:1-800 Contacts Shares Tips on How to Clean Lens Cases 2China Latanoprost Market Investigation Report 2015-2019 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 3Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 4Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 5
... The Cleveland Clinic and Valence Health announced today that ... become a clinically integrated network.  This new network, the ... physicians, and more than 1,000 private practitioners in the ... Physician Partnership (CPP), recognized the need to pursue Clinical ...
... Biotechnology, Inc. (OTC Bulletin Board: CSBR ), ... accelerating the development and enhancing the value of oncology ... Chief Financial Officer. Mr. Schonau indicated that he has ... other opportunities. Champions is seeking chief financial officer candidates ...
Cached Medicine Technology:Valence Health Selected by Cleveland Clinic to Support Clinical Integration Program 2Champions' CFO Resigns 2
Large, bright images from a bronchoscope designed for routine examination and treatment....
... The BF-1T40 has been designed with ... versatility in therapeutic applications. This permits the ... including those for electrosurgical procedures. In addition, ... wide field of view and a bright, ...
... High performance fiberoptic imaging from ... ,Olympus has improved its fiberscope range, ... specifications and enhanced image performance. Olympus ... instruments for diagnosis and therapy in ...
... scope designed specifically to enable direct inspection ... suitable for pediatric applications as well. Its ... mere 2.8mm across. As a result, insertion ... with greater ease. And since this sophisticated ...
Medicine Products: